Literature DB >> 8617513

Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

C Aslanidis1, S Ries, P Fehringer, C Büchler, H Klima, G Schmitz.   

Abstract

Cholesteryl ester storage disease (CESD) and Wolman disease are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL). We provide evidence that the strikingly more severe course of Wolman disease is caused by genetic defects of LAL that leave no residual enzyme activity. In a CESD patient, a G --> A mutation at position -1 of the exon 8 splice donor site results in skipping of exon 8 in 97% of the LAL hnRNA originating from this allele, while 3% are spliced correctly, resulting in full-length LAL enzyme. The mutant LAL mRNA codes for a protein lacking amino acids 254 to 277. On the other allele, a G --> T mutation leads to a premature stop codon at Gly245, resulting in inactive LAL enzyme. In addition, the previously identified Leu179 --> Pro mutation is present on this allele, and the LAL mRNA is rendered unstable by the premature stop codon. Analysis of two children with Wolman disease showed that both were homozygous for a G --> A mutation at position +1 of the same splice donor site as for the CESD patient, leading to skipping of exon 8. In contrast to the CESD patient, no correctly spliced mRNA was detectable. We have also expressed a wildtype LAL cDNA and the mutant LAL cDNA from one Wolman patient in Sf9 and H5 insect cells. We demonstrate that the LAL enzyme generated from the wildtype LAL cDNA was active in homogenates from Sf9 and H5 cells, while the enzyme with the internal deletion of 24 amino acids originating from the LAL cDNA of the Wolman patient was not. The combined data provide evidence that the only functionally relevant genetic difference between the Wolman patients and the CESD patient is that the splice defect in Wolman, which affects one of the invariable nucleotides of the splice consensus sequences (position +1), does not permit any correct splicing, whereas the defect observed in CESD (position -1) allows some correct splicing (3% of total LAL mRNA) and therefore the synthesis of functional enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617513     DOI: 10.1006/geno.1996.0162

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  29 in total

1.  Fatal genetic defect causing Wolman disease.

Authors:  E Mayatepek; U Seedorf; H Wiebusch; H Lenhartz; G Assmann
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

2.  Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report.

Authors:  Uta Drebber; Matthias Andersen; Hans U Kasper; Peter Lohse; Manfred Stolte; Hans P Dienes
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

Review 3.  Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.

Authors:  Hemant Chatrath; Steven Keilin; Bashar M Attar
Journal:  Dig Dis Sci       Date:  2008-05-14       Impact factor: 3.199

Review 4.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

5.  A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease.

Authors:  Philipp S Wild; Tanja Zeller; Arne Schillert; Silke Szymczak; Christoph R Sinning; Arne Deiseroth; Renate B Schnabel; Edith Lubos; Till Keller; Medea S Eleftheriadis; Christoph Bickel; Hans J Rupprecht; Sandra Wilde; Heidi Rossmann; Patrick Diemert; L Adrienne Cupples; Claire Perret; Jeanette Erdmann; Klaus Stark; Marcus E Kleber; Stephen E Epstein; Benjamin F Voight; Kari Kuulasmaa; Mingyao Li; Arne S Schäfer; Norman Klopp; Peter S Braund; Hendrik B Sager; Serkalem Demissie; Carole Proust; Inke R König; Heinz-Erich Wichmann; Wibke Reinhard; Michael M Hoffmann; Jarmo Virtamo; Mary Susan Burnett; David Siscovick; Per Gunnar Wiklund; Liming Qu; Nour Eddine El Mokthari; John R Thompson; Annette Peters; Albert V Smith; Emmanuelle Yon; Jens Baumert; Christian Hengstenberg; Winfried März; Philippe Amouyel; Joseph Devaney; Stephen M Schwartz; Olli Saarela; Nehal N Mehta; Diana Rubin; Kaisa Silander; Alistair S Hall; Jean Ferrieres; Tamara B Harris; Olle Melander; Frank Kee; Hakon Hakonarson; Juergen Schrezenmeir; Vilmundur Gudnason; Roberto Elosua; Dominique Arveiler; Alun Evans; Daniel J Rader; Thomas Illig; Stefan Schreiber; Joshua C Bis; David Altshuler; Maryam Kavousi; Jaqueline C M Witteman; Andre G Uitterlinden; Albert Hofman; Aaron R Folsom; Maja Barbalic; Eric Boerwinkle; Sekar Kathiresan; Muredach P Reilly; Christopher J O'Donnell; Nilesh J Samani; Heribert Schunkert; Francois Cambien; Karl J Lackner; Laurence Tiret; Veikko Salomaa; Thomas Munzel; Andreas Ziegler; Stefan Blankenberg
Journal:  Circ Cardiovasc Genet       Date:  2011-05-23

Review 6.  The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.

Authors:  Angelika L Erwin
Journal:  Therap Adv Gastroenterol       Date:  2017-04-26       Impact factor: 4.409

Review 7.  Biogenesis and functions of lipid droplets in plants: Thematic Review Series: Lipid Droplet Synthesis and Metabolism: from Yeast to Man.

Authors:  Kent D Chapman; John M Dyer; Robert T Mullen
Journal:  J Lipid Res       Date:  2011-11-01       Impact factor: 5.922

8.  Critical roles of lysosomal acid lipase in T cell development and function.

Authors:  Peng Qu; Hong Du; David S Wilkes; Cong Yan
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

9.  Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.

Authors:  Stuart A Scott; Benny Liu; Irina Nazarenko; Suparna Martis; Julia Kozlitina; Yao Yang; Charina Ramirez; Yumi Kasai; Tommy Hyatt; Inga Peter; Robert J Desnick
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

10.  A case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.

Authors:  S J Cameron; U Daimee; R C Block
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.